Remdesivir for the Treatment of Covid-19 — Final Report
2020 · New England Journal of Medicine · 7,611 citations
https://doi.org/10.1056/nejmoa2007764
C
C. Buddy Creech
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
210
Papers
15.5K
Citations
45
h-index
105
i10-index
C. Buddy Creech is an academic researcher from Vanderbilt University. The author has contributed to research in topics: Antimicrobial Resistance in Staphylococcus & Influenza Virus Research Studies & Streptococcal Infections and Treatments. The author has an h-index of 45, co-authored 179 publications.
ORCID: 0000-0002-8276-9053Papers by this author
worksEvaluation of mRNA-1273 Covid-19 Vaccine in Children 6 to 11 Years of Age
2022 · New England Journal of Medicine · 170 citations
https://doi.org/10.1056/nejmoa2203315
Short- vs Standard-Course Outpatient Antibiotic Therapy for Community-Acquired Pneumonia in Children
2022 · JAMA Pediatrics · 139 citations
https://doi.org/10.1001/jamapediatrics.2021.5547
Evaluation of mRNA-1273 Vaccine in Children 6 Months to 5 Years of Age
2022 · New England Journal of Medicine · 136 citations
https://doi.org/10.1056/nejmoa2209367
Outcomes at least 90 days since onset of myocarditis after mRNA COVID-19 vaccination in adolescents and young adults in the USA: a follow-up surveillance study
2022 · The Lancet Child & Adolescent Health · 76 citations
https://doi.org/10.1016/s2352-4642(22)00244-9
Comparison of the Respiratory Resistomes and Microbiota in Children Receiving Short versus Standard Course Treatment for Community-Acquired Pneumonia
2022 · mBio · 39 citations
https://doi.org/10.1128/mbio.00195-22
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat